Vanderbilt-Ingram Cancer Center: Lung Neoplasms trials

The registry lists 32 Lung Neoplasms studies with Vanderbilt-Ingram Cancer Center as lead sponsor. 4 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 1 5Phase 2 12Phase 4 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation SequencingRecruitingNCT06105801Phase 4
• Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerRecruitingNCT05501665Phase 1/2
• Molecular Predictors of Cancer in Patients at High Risk of Lung CancerRecruitingNCT00898313
• Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerRecruitingNCT00897117
• Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic TumorsCompletedNCT03583086Phase 1/2Results posted
• Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT00984542Phase 2Results posted
• Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00664105Phase 2Results posted
• Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00550537Phase 2Results posted
• Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLCTerminatedNCT00544648Phase 1/2Results posted
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerTerminatedNCT00520845Phase 2Results posted
• Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00469898Phase 2Results posted
• Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary NodulesActive, not recruitingNCT06638398Not applicable
• Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL TrialActive, not recruitingNCT06593106Not applicable
• Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung CancerTerminatedNCT06140407Phase 2
• Early Detection of Lung CancerActive, not recruitingNCT03181256
• Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation LoadsWithdrawnNCT03023904Phase 2
• Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerTerminatedNCT02937402Not applicable
• Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibWithdrawnNCT01928160Phase 2
• Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerTerminatedNCT01707823Early Phase 1
• Nashville Early Diagnosis Lung Cancer ProjectActive, not recruitingNCT01475500
• Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked CigarettesTerminatedNCT01141218
• Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorTerminatedNCT01096381
• Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy ParticipantsCompletedNCT00899457
• Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)TerminatedNCT00898209
• Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerCompletedNCT00897793
• Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung CancerCompletedNCT00897650
• Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung CancerTerminatedNCT00892801Phase 1
• Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00653250Not applicable
• Family Quality of Life Among Families With a Member Who is a Cancer PatientCompletedNCT00544336
• Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck CancerCompletedNCT00483639
• Erlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00416650Phase 2
• Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung CancerCompletedNCT00002519Phase 1